APYX Apyx Medical Corporation
Healthcare$4.13-2.82%ClosedMarket Cap: $172.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
13.57
P/S
3.09
EV/EBITDA
-60.97
DCF Value
$-5.08
FCF Yield
-5.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.3%
Operating Margin
-7.7%
Net Margin
-16.4%
ROE
-90.6%
ROA
-14.5%
ROIC
-8.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $12.5M | 37.4% | $-911.0K | $-2.1M | $— | — |
| Q4 null | $19.2M | -10.5% | $11.0K | $-1.3M | $— | — |
| FY null | $52.8M | 36.0% | $-6.4M | $-11.2M | $— | — |
| Q3 null | $12.9M | 64.4% | $-832.0K | $-2.0M | $— | — |
| Q2 null | $11.4M | 62.3% | $-2.6M | $-3.8M | $— | — |
| Q1 null | $9.4M | 60.1% | $-3.1M | $-4.2M | $— | — |
| Q4 null | $14.2M | 63.0% | $-3.0M | $-4.6M | $— | — |
| FY null | $48.1M | 61.0% | $-18.8M | $-23.5M | $— | — |
| Q3 null | $11.5M | 60.5% | $-3.6M | $-4.7M | $— | — |
| Q2 null | $12.1M | 23.1% | $-5.5M | $-6.6M | $— | — |
| Q1 null | $10.2M | 58.1% | $-6.6M | $-7.6M | $— | — |
| Q4 2023 | $14.7M | 27.7% | $-5.8M | $-9.6M | $-0.28 | — |